Jump to main content
Jump to site search

Issue 6, 2018
Previous Article Next Article

The role of aryl-topology in balancing between selective and dual 5-HT7R/5-HT1A actions of 3,5-substituted hydantoins

Author affiliations

Abstract

In order to search for active and selective serotonin 5-HT7R antagonists among 3,5-disubstituted arylpiperazine-imidazolidine-2,4-diones, the role of the introduction/deletion and the mutual orientation of aromatic rings was analyzed. Chemical modifications of 2nd generation lead structure of 3-(3-(4-(diphenylmethyl)piperazin-1-yl)-2-hydroxypropyl)-5-(4-fluorophenyl)-5-methylimidazolidine-2,4-dione (2, KKB16) were performed. New derivatives (4–18) were designed and synthesized. X-ray crystallographic analysis of the representative compound 5-(4-fluorophenyl)-3-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-5-methylimidazolidine-2,4-dione (3) was performed to support molecular modeling and SAR studies. The affinity for 5-HT7R, D2R and 5-HT1AR in radioligand binding assays for the entire series and ADME-Tox parameters in vitro for selected compounds (7, 10, and 13) were evaluated. Molecular docking and pharmacophore model assessment were performed. According to the obtained results, 5-methyl-5-naphthylhydantoin derivatives were found to be the new highly active 5-HT7R agents (Ki ≤ 5 nM) with significant selectivity over 5-HT1AR and D2R. On the contrary, the (1-naphthyl)piperazine moiety was gained with the potent dual 5-HT7R/5-HT1AR action (Ki: 11 nM/19 nM).

Graphical abstract: The role of aryl-topology in balancing between selective and dual 5-HT7R/5-HT1A actions of 3,5-substituted hydantoins

Back to tab navigation

Supplementary files

Publication details

The article was received on 27 Mar 2018, accepted on 04 May 2018 and first published on 08 May 2018


Article type: Research Article
DOI: 10.1039/C8MD00168E
Citation: Med. Chem. Commun., 2018,9, 1033-1044
  •   Request permissions

    The role of aryl-topology in balancing between selective and dual 5-HT7R/5-HT1A actions of 3,5-substituted hydantoins

    K. Kucwaj-Brysz, R. Kurczab, E. Żesławska, A. Lubelska, M. A. Marć, G. Latacz, G. Satała, W. Nitek, K. Kieć-Kononowicz and J. Handzlik, Med. Chem. Commun., 2018, 9, 1033
    DOI: 10.1039/C8MD00168E

Search articles by author

Spotlight

Advertisements